ArticleBMJ open2021

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing-remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis.

Samuel Lees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.